Navigation Links
New Study Shares Best Practices in Biopharma Public Relations
Date:11/6/2008

CHAPEL HILL, N.C., Nov. 6 /PRNewswire/ -- While Public Relations has long been used as a marketing tool by the pharmaceutical and biotechnology industries, its ability to reach consumers has never been greater. Web sites, online social networks, and blogs have joined the traditional press release as effective and low-cost methods that help drive sales. With this understanding, new research was conducted by Best Practices, LLC to identify what Public Relations activities are most effective at educating and informing consumers at different points in a product's lifecycle. These and other insights are now available in the newly published report, "Public Relations Excellence: Using PR to Launch, Grow and Extend Your Brands." Additional findings from this study include insights into what Public Relations channels, tactics and calls-to-action are most effective for reaching consumers of pharmaceutical products while providing three case studies highlighting successfully employed Public Relations tactics at different lifecycle stages.

To view the study abstract or complimentary summary of the full report "Public Relations Excellence: Using PR to Launch, Grow and Extend Your Brands," click on the following link http://www3.best-in-class.com/rr975.htm .

In a benchmarking study that included such influential companies as Abbott, AstraZeneca, Genentech, Johnson & Johnson, Novartis, Pfizer, and Wyeth, many key topics were covered, including:

-- PR strategies and tactics that are most effective at different

lifecycle stages

-- PR tools and calls to action that are most effective

-- Case studies that reveal effective PR practices

-- Web site resources that are most effective for consumers

-- Ideal budget ratios and performance measurements

-- Lessons learned and best practices

For more information on this report, contact Robert Naylo
'/>"/>

SOURCE Best Practices, LLC
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
3. Kline Study: Better Brushing Habits Boost European Oral Care Sales
4. Evotec to Present Details of the Positive Phase II Study in Insomnia With EVT 201 at the Worldsleep07 Congress in Cairns/Australia
5. NASA study will help stop stowaways to Mars
6. New Study Findings Confirm CLEXANE(R)/LOVENOX(R) Long-Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome
7. Study Published in Clinical Cancer Research Confirms Potential Of Peregrines Bavituximab Combined With Radiation In Lung Cancer
8. Evotec Reports Details of the Positive Proof-of-Concept Phase II Study in Insomnia With EVT 201
9. Study Supports Use of GlycoMark Blood Test to Evaluate Therapy in Children with Diabetes
10. Quigley Corporation Releases Update on Quigley Pharmas Phase IIb Clinical Study of QR-333 in Diabetic Peripheral Neuropathy
11. Biodel Inc. Announces VIAject(TM) Phase II Meal Study Data at the 2007 European Association for the Study of Diabetes Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... ITRA Global, one of the largest ... real estate, has further expanded its global reach with ... Brisbane, Western Australia, reports Mylinda Vick, CCIM, Chairman of ... Global / ACORPP (Australian Corporate Property and Projects) , ... property services to a wide range of clients in ...
(Date:12/19/2014)... Charm Sciences is pleased to announce that ... Aflatoxin M1 in raw commingled milk is the first ... The peer reviewed report of the validation by Technology ... and Fisheries Research (ILVO-T&V) has been published by the ... most toxic aflatoxin and a known carcinogen, can be ...
(Date:12/19/2014)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today ... privately held company based in Redwood ... big data platform for centralized management and processing ... on-market Genomic Management Solution, Bina-GMS 1 , empowers ... and scalable analyses to maximize the value of ...
(Date:12/19/2014)... , Dec. 19, 2014 Research and Markets ... addition of the "Technology Innovations in Smart ... http://photos.prnewswire.com/prnh/20130307/600769 ... Smart Fabrics" offers a detailed assessment on technological ... Key Findings: 1. The Smart ...
Breaking Biology Technology:ITRA Global Continues International Expansion in Perth and Brisbane, Australia 2Charm Sciences Achieves Independent Validation of First 15 Minute Quantitative Screening Method for Aflatoxin M1 2Roche acquires Bina Technologies and enters the genomic informatics market 2Roche acquires Bina Technologies and enters the genomic informatics market 3Technology Innovations in Smart Fabrics (Technical Insights) 2
... wrote about the negative effects of what I call process ... can be solved by changing the way work activities, responsibilities ... of sorting out problems is simple if something isnt ... wasnt designed properly in the first place. Fix the process ...
... Brother plays in concert. Source: Brother Pricks and Pumps Web ... and bagpipes, the Australian band Brother has created ... and emerged as a prolific figure in the world of ... advocates for research into the use of stem cells to ...
... Wis. Midwest biotech businesses will soon have a ... mission to Japan. , ,The Japan External Trade Organization, ... and corporations to Japan this September 25 through October ... and network with Japanese companies. , ,Governor Jim Doyle, ...
Cached Biology Technology:Human networks: an antidote to process ideology 2Human networks: an antidote to process ideology 3Human networks: an antidote to process ideology 4Aussie rock band to raise stem-cell awareness with Milwaukee concert 2Aussie rock band to raise stem-cell awareness with Milwaukee concert 3Aussie rock band to raise stem-cell awareness with Milwaukee concert 440 Midwest biotech organizations to explore Japanese partnerships 240 Midwest biotech organizations to explore Japanese partnerships 340 Midwest biotech organizations to explore Japanese partnerships 4
(Date:12/3/2014)... Dec. 2, 2014   Marvin Test Solutions ... test solutions for military, aerospace, and manufacturing organizations, ... its successful TS-900 PXI semiconductor test platform ... of high-end systems to customers at a fraction ... to traditional ATE. "Our semiconductor ...
(Date:11/21/2014)... , Nov. 20, 2014 Strict laws against ... are piloting the North American and European automotive sector ... growing, gesture recognition systems that are intuitive and able ... in the industry. New analysis from ... Recognition Market in Europe and ...
(Date:11/18/2014)... 17, 2014   News Highlights: ... to develop The Partners Data Lake, an agile ... Data Lake will allow researcher and clinicians to ... and the lives of patients , The ... activities across the Partners system, breaking down physical ...
Breaking Biology News(10 mins):Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 2Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 3Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 2Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 3Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 2Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 3Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 5
... appearing in Environmental Health Perspectives (EHP) ... for the Project on Emerging Nanotechnologies (PEN), focuses ... It provides an overview of current practices; ... safety implications; and possible future directions for nanoremediation. ...
... Grand Rapids, Mich. (July 8, 2009) ... a gene that could be an important therapeutic target ... breast cancer. Currently, patients with these cancers have few ... declining, but the cancers that don,t respond to traditional ...
... plant pathology and microbiology at Texas A&M University, has been ... Scholthof, who also has an appointment with Texas ... meeting Aug. 4 in Portland, Ore. ... or to the society. The ...
Cached Biology News:Contaminated site remediation: Are nanomaterials the answer? 2Possible drug target found for one of the most aggressive breast cancers 2
... serial preparation of four ... cytosol/particulate/cytoskeleton/nuclear fractions from one ... can directly be used ... as 2-D gel/Western blot/gel-shift/translocation/enzyme ...
Self Closing Forceps...
... Perfuse cells right in your ... The Petri dish Perfusion Chamber has ... outflow that dampen the fluctuations of ... compartment and prevent bubbles from entering ...
... Five cells (BTI-TN-5B1-4) derived from Trichoplusia ... shown to be capable of expressing ... proteins compared to other insect cells. ... features:- -Rapid doubling time as adherent cultures- Quick ...
Biology Products: